Related Experiment Videos
Influenza vaccination in 29 countries. An update to 1997
1Institute for Specific Prophylaxis and Tropical Medicine, University of Vienna, Austria.
Pharmacoeconomics
|January 6, 2000
Summary
Influenza vaccination rates are increasing or stabilizing globally, with notable rises in several European nations and the US. Despite progress, the full benefits of influenza vaccination remain unrealized in all countries.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- Influenza remains a significant global health concern, necessitating effective prevention strategies.
- Influenza vaccination is a key public health intervention to mitigate disease burden.
Purpose of the Study:
- To provide an updated analysis of influenza vaccination utilization across various countries for 1996 and 1997.
- To track trends in influenza vaccine uptake and identify factors influencing its use.
Main Methods:
- Data on influenza vaccine use from 1980-1995 were established in prior reports.
- The current study incorporates data from 29 countries for the years 1996 and 1997.
Main Results:
- Substantial increases in influenza vaccination were observed in the Netherlands, Finland, and Ireland.
- The US showed steady growth in vaccine use, reaching 281 doses per 1000 population in 1997.
- Age-based recommendations and reimbursement policies varied, with awareness and perceived vaccine effectiveness influencing uptake more than healthcare spending.
Conclusions:
- Influenza vaccination rates continue to rise or stabilize in developed nations and are emerging in developing countries.
- While progress has been made, the complete potential of influenza vaccination has not yet been achieved globally.